COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.
LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...
Friday is the 24th annual National Wear Red Day to raise awareness about heart disease. Wear Red Day is always the first Friday in February, which is American Heart Month. By wearing red, participants ...
Children's Hospital Los Angeles has reportedly paused the initiation of hormone therapy for new transgender youth patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback